June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Activation of NLRP3 by intracellular aggregates in RPE cells
Author Affiliations & Notes
  • Anu Kauppinen
    School of Pharmacy, University of Eastern Finland, Kuopio, Finland
  • Niina Piippo
    School of Pharmacy, University of Eastern Finland, Kuopio, Finland
  • Eveliina Korhonen
    School of Pharmacy, University of Eastern Finland, Kuopio, Finland
  • Maria Hytti
    School of Pharmacy, University of Eastern Finland, Kuopio, Finland
  • Kati Kinnunen
    Department of Ophthalmology, Kuopio University Hospital, Kuopio, Finland
  • Kai Kaarniranta
    Department of Ophthalmology, University of Eastern Finland, Kuopio, Finland
    Department of Ophthalmology, Kuopio University Hospital, Kuopio, Finland
  • Footnotes
    Commercial Relationships   Anu Kauppinen, None; Niina Piippo, None; Eveliina Korhonen, None; Maria Hytti, None; Kati Kinnunen, None; Kai Kaarniranta, None
  • Footnotes
    Support  The Academy of Finland (grants 297267 and 307341), the Emil Aaltonen Foundation
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 5742. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Anu Kauppinen, Niina Piippo, Eveliina Korhonen, Maria Hytti, Kati Kinnunen, Kai Kaarniranta; Activation of NLRP3 by intracellular aggregates in RPE cells. Invest. Ophthalmol. Vis. Sci. 2017;58(8):5742.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : NLRP3 inflammasome promotes inflammation by the caspase-1-mediated release of IL-1β and IL-18, and its activation has been associated with the pathogenesis of age-related macular degeneration (AMD). We have previously shown that insufficient degradation of intracellular waste material serves as an activation signal for NLRP3 in human retinal pigment epithelial (RPE) cells. NLRP3 is a pattern recognition receptor (PRR) with several activation mechanisms, and in this study, we have explored the mechanism(s) contributing to the inflammasome activation induced by dysfunctional intracellular cleaning.

Methods : NLRP3 was activated in IL-1α-primed human ARPE-19 cells by the proteasome inhibitor MG-132 and the autophagy inhibitor Bafilomycin A. We measured extracellular ATP using a commercial kit, and inhibited ATP-receptors by a P2X7 inhibitor in cell cultures. For preventing potassium efflux, cell cultures were exposed to high extracellular potassium concentration or glyburide. Cathepsin B activity was measured using a commercial assay. In order to study the role of oxidative stress, mitoTEMPO, APDC (ammonium pyrrolidine dithiocarbamate), or NAC (N-acetylcysteine) were added to the cell cultures. Cellular reactive oxygen species (ROS) were detected using the DCFDA (2’,7’-dichlorofluorescin diacetate) assay.

Results : Inhibition of P2X7 receptors did not prevent the secretion of IL-1β although increased levels of extracellular ATP could have been able to initiate the response. Blocking the potassium efflux showed a weak response but cathepsin B seemed not to play any role in the inflammasome activation in our model. The treatment increased intracellular oxidative (P < 0.001), and ROS inhibitors mitoTEMPO (P < 0.05) and APDC (P < 0.001) but not NAC alleviated the release of IL-1β.

Conclusions : According to our results, oxidative stress plays a major role in the activation of NLRP3 inflammasome in human RPE cells with declined functionality of intracellular clearance systems. Especially inhibitors of NADPH oxidase and mitochondria-derived ROS appeared efficient.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×